Mixing of Covaxin and Covishield to be carried out

A study regarding the mixing of two vaccines, Covaxin and Covishield is been given a heads up. These are the two main vaccines used in India right now. The DCGI has approved the mixing of these two vaccines.

The clinical trails of the vaccines will take place in Vellore, at Vellore&rsqu...

Adar Poonawalla helps Indian Students studying abroad

The CEO of Serum group of Institutes, Adar Poonawalla has said on Thursday that he has set aside 10 crore rupees for students studying abroad. Covishield, made by Serum group of Institutes, is not yet accepted by many nations.

On Thursday, he said that not many nations have approved Cov...

NEW SCHEDULE FOR COVISHIELD

Highlights:

• The new dosing schedule for Covishield, the Indian vaccine for coronavirus has been updated in CoWin.
• The new dosing schedule will allow the person to get the second shot of the virus after 12-16 weeks of taking the first shot.
• ...

COVISHIELD VACCINE MAYBE RECOMMENDED FOR INTERNATIONAL USE

HIGHLIGHTS

• AstraZeneca is in talks with governments of many countries.
• AstraZeneca is also engaging with multilateral organizations and many other partners around the world.
• AstraZeneca wants broad and equitable access to the vaccine for ev...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY

According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to det...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...